References - Sleep Mood Protocol

1.    Oh R.  "Practical applications of fish oil (Omega-3 fatty acids) in primary care."  J Am Board Fam Pract. 2005 Jan-Feb;18(1):28-36.     

2.    Reiffel JA, McDonald A.  "Antiarrhythmic effects of omega-3 fatty acids." Am J Cardiol. 2006 Aug 21;98(4A):50i-60i.          
3.    Robinson JG, Stone NJ.  "Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids." Am J Cardiol. 2006 Aug 21;98(4A):39i-49i.         

4.    Davidson MH.  "Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids." Am J Cardiol. 2006 Aug 21;98(4A):27i-33i.    

5.    Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J.  "n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies"     

6.    Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J.  "Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review." Atherosclerosis. 2006 Nov;189(1):19-30.          

7.    Mickleborough TD.  "Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma."  J Asthma. 2005 Jun;42(5):305-14.           

 
8.    Wild GE, Drozdowski L, Tartaglia C, Clandinin MT, Thomson AB. "Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical." World J Gastroenterol. 2007 Jan 7;13(1):1-7.     

9.    Peet M, Stokes C.  "Omega-3 fatty acids in the treatment of psychiatric disorders." Drugs. 2005;65(8):1051-9.      

10.    Al-Hasani H, Joost HG.  "Nutrition-/diet-induced changes in gene expression in white adipose tissue." Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):589-603.      

11.    Azain MJ.  "Role of fatty acids in adipocyte growth and development." J Anim Sci. 2004 Mar;82(3):916-24.      

12.    James MJ, Proudman SM, Cleland LG.  "Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis."  Prostaglandins Leukot Essent Fatty Acids. 2003 Jun;68(6):399-405.             
13.    Simopoulos AP.  "Omega-3 fatty acids in inflammation and autoimmune diseases."  J Am Coll Nutr. 2002 Dec;21(6):495-505.

14.    Calder PC, Grimble RF. "Polyunsaturated fatty acids, inflammation and immunity."  Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S14-9.

15.    Watkins BA, Li Y, Lippman HE, Seifert MF.  "Omega-3 polyunsaturated fatty acids and skeletal health." Exp Biol Med (Maywood). 2001 Jun;226(6):485-97.      

16.    http://www.umm.edu/altmed/ConsSupplements/Interactions/Omega3FattyAcidscs.html  

     
17.    Turner EH, Loftis JM, Blackwell AD. "Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan."  Pharmacol Ther. 2006 Mar;109(3):325-38.                 

18.    Amer A, Breu J, McDermott J, et al.  "5-Hydroxy-L-tryptophan suppresses food intake in food-deprived and stressed rats."  Pharmacol Biochem Behav. 2004 Jan;77(1):137-43.          

       
19.    Cangiano C, Laviano A, Del Ben M,et al.  "Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients."  Int J Obes Relat Metab Disord. 1998 Jul;22(7):648-54.

20.    Birdsall TC.  "5-Hydroxytryptophan: a clinically-effective serotonin precursor."  Altern Med Rev. 1998 Aug;3(4):271-80.           

     
21.    Kahn RS, Westenberg HG, Verhoeven WM, et al.   "Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo." Int Clin Psychopharmacol. 1987 Jan;2(1):33-45.     

22.    Fu AL, Wu SP, Dong ZH, Sun MJ.  "A novel therapeutic approach to depression via supplement with tyrosine hydroxylase." Biochem Biophys Res Commun. 2006 Dec 8;351(1):140-5.            

23.    Fernstrom JD. "Can nutrient supplements modify brain function?"  Am J Clin Nutr. 2000 Jun;71(6 Suppl):1669S-75S.         
24.    Birdsall TC.  "5-Hydroxytryptophan: a clinically-effective serotonin precursor."  Altern Med Rev. 1998 Aug;3(4):271-80.

25.    Baldrick P, Richardson D, Wheeler AW.  "Review of L-tyrosine confirming its safe human use as an adjuvant." J Appl Toxicol. 2002 Sep-Oct;22(5):333-44.

26.    van Spronsen FJ, van Rijn M, Bekhof J. "Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets." Am J Clin Nutr 2001;73:153-7.

27.    PDR for Nutritional Supplements, 1st edition (2001).

28.    [No authors listed]  L-Tryptophan. Monograph.  Altern Med Rev. 2006 Mar;11(1):52-6.         

29.    Boman B.  "L-tryptophan: a rational anti-depressant and a natural hypnotic?"  Aust N Z J Psychiatry. 1988 Mar;22(1):83-97.      

           
30.    Esteban S, Nicolaus C, Garmundi A, Rial RV, Rodriguez AB, Ortega E, Ibars CB.  "Effect of orally administered L-tryptophan on serotonin, melatonin, and the innate immune response in the rat." Mol Cell Biochem. 2004 Dec;267(1-2):39-46.      

   
31.    aan het Rot M, Moskowitz DS, Pinard G, Young SN.  "Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals." J Psychiatry Neurosci. 2006 Jul;31(4):253-62.     

 

     32.    Bailara KM, Henry C, Lestage J, et al.  "Decreased brain tryptophan availability as a partial determinant of post-partum blues." Psychoneuroendocrinology. 2006 Apr;31(3):407-13.         

       
33.    Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D.  "Monitoring tryptophan metabolism in chronic immune activation." Clin Chim Acta. 2006 Feb;364(1-2):82-90.

34.    [No authors listed]  L-Tryptophan. Monograph.  Altern Med Rev. 2006 Mar;11(1):52-6.

35.    Birdsall TC.  "Therapeutic applications of taurine." Altern Med Rev. 1998 Apr;3(2):128-36.  

       
36.    Bidri M, Choay P.  "[Taurine: a particular aminoacid with multiple functions]" Ann Pharm Fr. 2003 Nov;61(6):385-91.                 
37.    Kendler BS.  "Taurine: an overview of its role in preventive medicine."  Prev Med. 1989 Jan;18(1):79-100.

38.    Stapleton PP, Charles RP, Redmond HP, Bouchier-Hayes DJ.  "Taurine and human nutrition." Clin Nutr. 1997 Jun;16(3):103-8.      

       
39.    Lourenco R, Camilo ME.  "Taurine: a conditionally essential amino acid in humans? An overview in health and disease." Nutr Hosp. 2002 Nov-Dec;17(6):262-70.

40.    Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F.  "The important role of taurine in oxidative metabolism."  Adv Exp Med Biol. 2006;583:129-35.     

41.    Mas MR, Isik AT, Yamanel L, Inal V, Tasci I, Deveci S, Mas N, Comert B, Akay C.   "Antioxidant treatment with taurine ameliorates chronic pancreatitis in an experimental rat model."  Pancreas. 2006 Jul;33(1):77-81.   

     
42.    Franconi F, Loizzo A, Ghirlanda G, Seghieri G.  "Taurine supplementation and diabetes mellitus." Curr Opin Clin Nutr Metab Care. 2006 Jan;9(1):32-6.     

43.    Franconi F, Di Leo MA, Bennardini F, Ghirlanda G.  "Is taurine beneficial in reducing risk factors for diabetes mellitus?" Neurochem Res. 2004 Jan;29(1):143-50.     

44.    Atmaca G.  "Antioxidant effects of sulfur-containing amino acids."  Yonsei Med J. 2004 Oct 31;45(5):776-88. 

 

45.    Shils ME, Olson JA, Shike M (eds.) (1994) Modern Nutrition in Health and Disease, Eighth Edition. Chapters 20-26, 28, 30. Lea & Febiger Philadelphia.    

 

46.    Chang EB, Sitrin MD, Black DD (1996) Gastrointestinal, Hepatobiliary, and Nutritional Physiology.  Chapter 9, Absorption of Water-Soluble Vitamins and Minerals.  Lippincott-Ravin, Philadelpia

47.    de Graaff MJ, Buijs RM, Hoekstra JB, Fliers E, Holleman F. "[Melatonin: physiological and pathophysiological aspects and possible applications]" Ned Tijdschr Geneeskd. 2006 Sep 9;150(36):1971-5. Review. Dutch.     

48.    Dawson D, van den Heuvel CJ.  "Integrating the actions of melatonin on human physiology." Ann Med. 1998 Feb;30(1):95-102. Review.          

   
49.    Shochat T, Haimov I, Lavie P.  "Melatonin--the key to the gate of sleep."  Ann Med. 1998 Feb;30(1):109-14.

50.    Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD. "Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia." J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):512-9.    

51.    Karasek M, Reiter RJ, Cardinali DP, Pawlikowski M.   "Future of melatonin as a therapeutic agent."  Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:118-21. Review.

52.    Bottiglieri T (2002) "S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule."    Am J Clin Nutr 76(Suppl):1151S-157S.

53.    Williams AL, Girard C, Jui D, Sabina A, Katz  "DL.S-adenosylmethionine (SAMe) as treatment for depression: a systematic review." Clin Invest Med. 2005 Jun;28(3):132-9

54.    Ilich JZ, Kerstetter JE (2000) Nutrition in Bone Health Revisited: A Story Beyond Calcium. J Am Coll Nutr19(6):715-737.              

 
55.    Rude RK, Shils ME (2006) In: Modern Nutrition in Health and Disease,  Magnesium, Chapter 11, Shils ME,  Shike M, Ross AC, Caballero B, Cousins RJ, Eds., Lippincott Williams & Wilkins, Baltimore, MD.

56.    Sufka KJ, Roach JT, Chambliss WG Jr, Broom SL, Feltenstein MW, Wyandt CM, Zeng L. "Anxiolytic properties of botanical extracts in the chick social separation-stress procedure."  Psychopharmacology (Berl). 2001 Jan 1;153(2):219-24.         
57.    Garrison R, Chambliss WG.  "Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial."  Altern Ther Health Med. 2006 Jan-Feb;12(1):50-4.     

            
58.    Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M. "Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome." Life Sci. 2006 Nov 25;79(26):2474-9.         

59.    Mattioli L, Perfumi M.  "Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats." J Psychopharmacol. 2007 Jan 26; [Epub ahead of print]

60.    Perfumi M, Mattioli L.    "Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice." Phytother Res. 2007 Jan;21(1):37-43.

 

61.    Maslova LV, Kondrat'ev BIu, Maslov LN, Lishmanov IuB.  "[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress]"  Eksp Klin Farmakol. 1994 Nov-Dec;57(6):61-3.

 

62.    De Bock K, Eijnde BO, Ramaekers M, Hespel P.   "Acute Rhodiola rosea intake can improve endurance exercise performance." Int J Sport Nutr Exerc Metab. 2004 Jun;14(3):298-307.  

           
63.    Choo JJ.  "Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue." J Nutr Biochem. 2003 Nov;14(11):671-6.         

64.    Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I, Hase T.  "Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise."  Am J Physiol Regul Integr Comp Physiol. 2006 Jun;290(6):R1550-6.  

   
65.     [No authors listed]  Monograph. Withania somnifera.  Altern Med Rev. 2004 Jun;9(2):211-4.